U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Differences in Hypertension and Stage II Hypertension by Demographic and Risk Factors, Obtained by Two Different Protocols in US Adults: National Health and Nutrition Examination Survey, 2017–2018

Supporting Files
File Language:
English


Details

  • Alternative Title:
    Am J Hypertens
  • Personal Author:
  • Description:
    BACKGROUND

    To compare prevalence of hypertension and stage II hypertension assessed by 2 blood pressure (BP) observation protocols.

    METHODS

    Participants aged 18 years and older (n = 4,689) in the National Health and Nutrition Examination Survey (NHANES 2017–2018) had their BP measured following 2 protocols: the legacy auscultation protocol (AP) and oscillometric protocol (OP). The order of protocols was randomly assigned. Prevalence estimates for hypertension (BP ≥130/80 mm Hg or use of medication for hypertension) and stage II hypertension (BP ≥140/90 mm Hg) were determined overall, by demographics, and by risk factors for each protocol. Ratios (OP% ÷ AP%) and kappa statistics were calculated.

    RESULTS

    Age-adjusted hypertension prevalence was 44.5% (95% confidence interval [CI]: 41.1%–48.0%) using OP and 45.1% (95% CI: 41.5%–48.7%) using AP, prevalence ratio = 0.99 (95% CI = 0.94–1.04). Age-adjusted stage II hypertension prevalence was 15.8% (95% CI: 13.6%–18.2%) using AP and 17.1% (95% CI: 14.7%–19.7%) using OP, prevalence ratio = 0.92 (95% CI = 0.81–1.04). For both hypertension and stage II hypertension, the prevalence ratios by demographics and by risk factors all included unity in their 95% CI, except for stage II hypertension in adults 60+ years (ratio: 0.88 [95% CI: 0.78–0.98]). Kappa for agreement between protocols for hypertension and stage II hypertension was 0.75 (95% CI = 0.71–0.79) and 0.67 (95% CI = 0.61–0.72), respectively.

    CONCLUSIONS

    In adults and for nearly all subcategories there were no significant differences in prevalence of hypertension and stage II hypertension between protocols, indicating that protocol change may not affect the national prevalence estimates of hypertension and stage II hypertension.

  • Subjects:
  • Keywords:
  • Source:
    Am J Hypertens. 35(7):619-626
  • Pubmed ID:
    35333925
  • Pubmed Central ID:
    PMC9745726
  • Document Type:
  • Funding:
  • Volume:
    35
  • Issue:
    7
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:5baf16ed7b7bcb0de556f06e0855b2f86b8276b6d1b05fef3185b64827b8b824a51102482d298b4a35d78bedba80172a8f69bc1e318dbfc987b0b846b9d3b857
  • Download URL:
  • File Type:
    Filetype[PDF - 567.71 KB ]
File Language:
English
ON THIS PAGE

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.